Pityriasis rosea - I-Pityriasis Rosea
☆ AI Dermatology — Free Service
Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
I-Pityriasis Rosea (Pityriasis rosea) ivela ngemuva — ama-macules nama-patches awabonakali, ngokungafani nokuqhuma kwezidakamizwa okuvame ukulunywa.
Uma ulunywa kakhulu, ungase ube nesifo esifana ne-nummular eczema.
relevance score : -100.0%
ReferencesI-Pityriasis rosea yisimo sesikhumba sesikhashana esibonakala ngamabala aphakanyisiwe nezikali. Ngokuvamile, iqala ngophawu olulodwa olubizwa ngokuthi i-herald patch, kulandele amanye amapheshana avela emasontweni ambalwa alandelayo. Kodwa-ke, akuwona wonke umuntu one-Pityriasis rosea ozoba nalolu phawu lokuqala. Lezi ziqephu zivame ukuhleleka ngendlela ehlukile efana nesihlahla sikaKhisimusi esiqwini nasemithanjeni engaphezulu.
Pityriasis rosea, also known as pityriasis circinata, roseola annulata, and herpes tonsurans maculosus is an acute self-limiting papulosquamous disorder. It is often characterized by an initial herald patch, followed by scaly oval patches within 2 weeks. However, the herald patch is not always present. The scaly oval patches typically distribute in a Christmas-tree pattern on the trunk and proximal extremities. This activity reviews the evaluation and treatment of pityriasis rosea and the importance of the interprofessional team in recognizing and managing patients with this condition.
Pityriasis rosea, also known as pityriasis circinata, roseola annulata, and herpes tonsurans maculosus is an acute self-limiting papulosquamous disorder. It is often characterized by an initial herald patch, followed by scaly oval patches within 2 weeks. However, the herald patch is not always present. The scaly oval patches typically distribute in a Christmas-tree pattern on the trunk and proximal extremities. This activity reviews the evaluation and treatment of pityriasis rosea and the importance of the interprofessional team in recognizing and managing patients with this condition.
I- Pityriasis rosea ukuqubuka okuvamile okuvame ukuqala ngesichibi esisodwa esiqwini bese kusabalala ukuvala isiqu nezitho. Ukuxilongwa kuncike ekuhlolweni komtholampilo. Isiqephu sokuqala sibonakala sibomvu ngomngcele ophakanyisiwe kanye nendawo eshonelwe. Ukuqubuka ngokuvamile kuvela emasontweni amabili kamuva. Iziguli zingase zizwe ukukhathala, isicanucanu, ikhanda, ubuhlungu bamalunga, ukuvuvukala kwama-lymph nodes, imfiva, nomphimbo obuhlungu eduze nokuqubuka. Izimo ezifanayo zihlanganisa i-syphilis, i-seborrheic dermatitis, i-eczema, nezinye. Ukwelashwa kuhloswe ukudambisa izimpawu nge-corticosteroids noma ama-antihistamine. I-Acyclovir ingasiza kwezinye izimo. Izimo ezinzima zingazuza ku-UV phototherapy. Lesi sifo ngesikhathi sokukhulelwa ngezinye izikhathi siye sahlotshaniswa nokuphuphuma kwesisu.
Pityriasis rosea is a common rash that usually begins with a single patch on the trunk and spreads to cover the trunk and limbs. Diagnosis relies on clinical examination. The initial patch appears red with a raised border and sunken center. The rash typically emerges about two weeks later. Patients may experience fatigue, nausea, headaches, joint pain, swollen lymph nodes, fever, and sore throat alongside the rash. Similar conditions include syphilis, seborrheic dermatitis, eczema, and others. Treatment aims to alleviate symptoms with corticosteroids or antihistamines. Acyclovir may help in some cases. Severe instances may benefit from UV phototherapy. The disease during pregnancy sometimes has been linked to miscarriage.
Pityriasis rosea is a common rash that usually begins with a single patch on the trunk and spreads to cover the trunk and limbs. Diagnosis relies on clinical examination. The initial patch appears red with a raised border and sunken center. The rash typically emerges about two weeks later. Patients may experience fatigue, nausea, headaches, joint pain, swollen lymph nodes, fever, and sore throat alongside the rash. Similar conditions include syphilis, seborrheic dermatitis, eczema, and others. Treatment aims to alleviate symptoms with corticosteroids or antihistamines. Acyclovir may help in some cases. Severe instances may benefit from UV phototherapy. The disease during pregnancy sometimes has been linked to miscarriage.
In most cases, PR does not influence pregnancy or birth outcomes. Analysis of pooled data from our study and from previous studies revealed that the week of pregnancy at onset of PR was inversely associated with an unfavorable outcome (odds ratio [OR] = 0.937; 95 % CI 0.883 to 0.993). In addition, duration of PR (OR = 1.432; 95 % CI 1.129 to 1.827), additional extracutaneous symptoms (OR = 4.112; 95 % CI 1.580 to 10.23), and widespread rash distribution (OR 5.203, 95 % CI 1.702 to 14.89) were directly associated with unfavorable outcome.
I- Pityriasis rosea yisimo sesikhumba esivamile esihlasela intsha kanye nabantu abadala abasebasha (abaneminyaka engu-10-35) , kancane kancane kwabesifazane. Iqala ngokuzumayo, imvamisa ngesiqeshana esisodwa esaziwa ngokuthi Herald patch esiqwini, okulandelwa ukuqubuka kwamachashaza amise okweqanda apinki azungezwe indandatho empunga. Lawa machashazi ngokuvamile enza iphethini efana ne- Christmas tree esiqwini. Ukuqubuka ngokuvamile kuthatha amasonto ayisi-6 kuya kwayi-8. Pityriasis rosea ithinta cishe u-0. 68% wabantu ababona udokotela wesikhumba, kodwa lokhu kungahluka kusuka ku-0. 39% kuya ku-4. 8%.
Pityriasis rosea (PR) is a relatively common, self-limited papulo-squamous dermatosis of unknown origin, which mainly appears in adolescents and young adults (10-35 years), slightly more common in females. It has a sudden onset, and in its typical presentation, the eruption is preceeded by a solitary patch termed “herald patch”, mainly located on the trunk. Few days later, a secondary eruption appears, with little pink, oval macules, with a grayish peripheral scaling collarette around them. The secondary lesions adopt a characteristic distribution along the cleavage lines of the trunk, with a configuration of a “Christmas tree”. In most cases, the eruption lasts for 6 to 8 wk. Its incidence has been estimated to be 0.68% of dermatologic patients, varying from 0.39% to 4.8%.
Pityriasis rosea (PR) is a relatively common, self-limited papulo-squamous dermatosis of unknown origin, which mainly appears in adolescents and young adults (10-35 years), slightly more common in females. It has a sudden onset, and in its typical presentation, the eruption is preceeded by a solitary patch termed “herald patch”, mainly located on the trunk. Few days later, a secondary eruption appears, with little pink, oval macules, with a grayish peripheral scaling collarette around them. The secondary lesions adopt a characteristic distribution along the cleavage lines of the trunk, with a configuration of a “Christmas tree”. In most cases, the eruption lasts for 6 to 8 wk. Its incidence has been estimated to be 0.68% of dermatologic patients, varying from 0.39% to 4.8%.
Noma imbangela ingacacile ngokuphelele, kukholakala ukuthi ihlobene ne-herpesvirus yomuntu 6 noma i-herpesvirus yomuntu 7. Ayibonakali ukuthi iyasabalala. Imithi ethile ingase ibangele ukuqubuka okufanayo. Ukuxilongwa kusekelwe ezimpawini, futhi i-biopsy ngokuvamile ayidingeki.
Njengesifo esivamile, cishe i-1.3% yabantu iyathinteka. Ngokuvamile kwenzeka kubantu abaneminyaka ephakathi kuka-10 no-35.
○ Ukuxilongwa Nokwelashwa
Uma izimpawu ziqhubeka isikhathi esingaphezu kwenyanga, kungadingeka ukuhlola ngokucophelela ukuze kuhlukaniswe nezinye izifo (parapsoriasis, syphilis).
#Phototherapy
#OTC steroid ointment